文献速递胸部肿瘤

骨髓间充质干细胞多途径促进肺癌进展的机制研究

[Multi-channel promotion of lung cancer progress by bone marrow derived mesenchymal stem cells in tumor microenvironment].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2018-01-01

该研究在NOD小鼠中观察到骨髓间充质干细胞(BMSCs)向肺癌特异性趋化并促进肿瘤生长与转移,体外实验显示BMSCs增强肺癌细胞迁移侵袭并下调E-Cadherin,IL-6和PGE2可能是关键旁分泌因子。

要点

  • BMSCs可缩短肺癌成瘤时间、提高成瘤率并增大肿瘤体积。
  • BMSCs促进肺癌转移并增加肿瘤微血管密度。
  • IL-6和PGE2可能是BMSCs促肺癌进展的关键细胞因子。

核心结论

  • BMSCs可能通过促微血管形成促进肺癌生长,并通过旁分泌和下调E-Cadherin促进转移。
  • IL-6和PGE2可能是BMSCs发挥作用的主要细胞因子。

研究设计与样本

  • 研究在NOD小鼠体内观察BMSCs的肿瘤趋向性及对成瘤和转移的影响。
  • 体外采用划痕实验和Transwell实验评估BMSCs对A549和H446细胞迁移侵袭的影响。
  • 通过共培养和Western blot检测BMSCs对肺癌细胞上皮间质转化的影响。
  • 采用ELISA筛选BMSCs可能的关键可溶性因子。

主要发现

  • A549+BMSCs组和A549组成瘤时间分别为(5.0±1.5)d和(10.0±3.6)d,P<0.05。
  • H446+BMSCs组和H446组成瘤时间分别为(5.2±1.5)d和(12.0±2.0)d,P<0.05。
  • A549+BMSCs组和A549组成瘤率分别为100.0%和66.7%,P<0.05;H446+BMSCs组和H446组分别为83.0%和50.0%,P<0.05。
  • A549+BMSCs组和A549组肿瘤体积分别为(193.0±42.3)mm³和(97.8±42.9)mm³,P<0.05;H446+BMSCs组和H446组分别为(78.6±34.8)mm³和(25.3±12.7)mm³,P<0.05。
  • A549+BMSCs组和A549组转移率分别为100.0%和16.7%,P<0.05;H446+BMSCs组和H446组分别为100.0%和0.0%,P<0.05。

关键数值与推荐

  • A549+BMSCs组和A549组MVD分别为53.2±11.4和25.3±11.5,P<0.05;H446+BMSCs组和H446组分别为56.8±12.5和24.8±10.0,P<0.05。
  • A549细胞对照组和实验组下室吸光度分别为1.1±0.1和1.9±0.2,P<0.05;H446细胞对照组和实验组分别为0.9±0.2和1.9±0.3,P<0.05。
  • A549细胞对照组和实验组E-Cadherin表达水平分别为0.55和0.36,P<0.05;H446细胞对照组和实验组分别为0.46和0.28,P<0.05。
  • BMSCs条件介质中IL-6浓度为910.5,A549共培养组为957.2,H446共培养组为963.8,均显著高于对照组18.8,P<0.05。
  • A549共培养组和H446共培养组PGE2表达水平分别为130.5和87.2,显著高于对照组13.8和BMSCs组23.8,P<0.05。

临床怎么用

  • 提示BMSCs是肺癌微环境中促进生长和转移的重要因素,可能成为潜在干预靶点。
  • IL-6和PGE2通路值得在肺癌微环境研究中进一步关注。

局限性

  • 研究主要基于NOD小鼠和A549、H446细胞系,结论外推至临床需谨慎。
  • IL-6和PGE2仅为初筛的潜在关键因子,其因果作用尚未充分验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To observe the growth and metastasis of lung cancer promoted by bone marrow derived mesenchymal stem cells (BMSCs) in tumor microenvironment and investigate the underlined mechanisms. Methods: Specific chemotaxis of BMSCs towards lung cancer was observed, and the tumor growth and metastasis were assessed in vivo. Furthermore, CD34 expression determined by immunohistochemistry was used to assess the microvessel density (MVD), and the expressions of GFP and α-SMA determined by immunofluorescence were used to detect the BMSCs derived mesenchymal cells. We investigated the effect of BMSCs on migration, invasion of lung cancer cells including A549 and H446 cells by using scratch assays and Transwell Assay in vitro. We also explored the effect of BMSCs on epithelial mesenchymal transition of A549 and H446 cells by observing the phenotype transition and E-Cadherin protein expression detected by Western blot. At last, we screened the potentially key soluble factors by enzyme linked immunosorbent assay (ELISA). Results: In NOD mice, labeled BMSCs injected via tail vein were special chemotaxis to tumor cells, and promoted the tumor growth [the time of tumor formation in A549+ BMSCs and A549 alone was (5.0±1.5) days and (10.0±3.6) days, respectively, P<0.05; the time of tumor formation in H446+ BMSCs and H446 alone was (5.2±1.5) days and (12.0±2.0) days, respectively, P<0.05]. The tumor incidence of A549+ BMSCs was 100%, significantly higher than 66.7% of A549 alone (P<0.05), while the tumor incidence of H446+ BMSCs was 83.0%, significantly higher than 50.0% of H446 alone (P<0.05). The BMSCs also increased the tumor volume [the tumor volume of A549+ BMSCs and A549 alone was (193.0±42.3) mm(3) and (97.8±42.9) mm(3,) respectively, P<0.05; the tumor volume of H446+ BMSCs and H446 alone was (78.6±34.8) mm(3) and (25.3±12.7) mm(3,) respectively, P<0.05] and facilitated the tumor metastasis (the tumor metastatic incidence of A549+ BMSCs and A549 alone was 100.0% and 16.7%, respectively, P<0.05; the tumor metastatic incidence of H446+ BMSCs and H446 alone was 100.0% and 0.0%, respectively, P<0.05). Furthermore, BMSCs increased tumor vessel formation (the MVD of A549+ BMSCs and A549 alone was 53.2±11.4 and 25.3±11.5, respectively, P<0.05; the MVD of H446+ BMSCs and H446 alone was 56.8±12.5 and 24.8±10.0, respectively, P<0.05). BMSCs were able to differentiate to fibroblasts in the lung squamous cell carcinoma and promoted the migration and invasion of lung cancer cells (the A of cells in the migrated lower chambers of A549+ BMSCs and A549 alone was 1.9±0.2 and 1.1±0.1, respectively, P<0.05; the A of cells in the migrated lower chambers of H446+ BMSCs and H446 alone was 1.9±0.3 and 0.9±0.2, respectively, P<0.05). The cell shape was longer and sharper, the intercellular junctions were reduced and the relative expression level of E-Cadherin protein in A549 co-cultured with BMDCs was 0.36, significantly down-regulated when compared to 0.55 of A549 alone (P<0.05), and the relative expression level of E-Cadherin protein in H446 co-cultured with BMDCs was 0.28, significantly down-regulated when compared to 0.46 of H446 cells alone (P<0.05). The concentration of IL-6 in the conditional medium of BMSCs, A549 co-cultured with BMSCs and H446 co-cultured with BMSCs was 910.5, 957.2, and 963.8, respectively, significantly up-regulated when compared to 18.8 of control group (P<0.05). The expression level of PGE2 in A549 co-cultured with BMSCs and H446 co-cultured with BMSCs was 130.5 and 87.2, significantly up-regulated when compared to 13.8 of control group and 23.8 of BMSCs group (P<0.05). Conclusions: Our results suggest that BMSCs contribute to the tumor growth through facilitating angiogenesis, and promote tumor metastasis through paracrine manner and down-regulation of E-Cadherin protein. IL-6 and PGE2 produced by BMDCs might be the potentially important cytokines. 目的: 观察骨髓间充质干细胞(BMSCs)对肺癌生长、转移等进展的影响,并探讨可能的分子机制。 方法: 在活体裸鼠观察BMSCs的肿瘤趋向性及成瘤大小、转移情况,采用CD34免疫组化染色检测肿瘤微血管密度(MVD),采用GFP/α-SMA免疫荧光双标法检测BMSCs来源的肺癌间质细胞。在体外,利用划痕实验、侵袭实验比较BMSCs对A549和H446细胞迁移、侵袭能力的影响,通过细胞共培养和Western blot检测观察BMSCs对A549和H446细胞向间质转化的影响。通过酶联免疫吸附试验检测、初筛出可能发挥关键作用的细胞因子。 结果: 经裸鼠尾静脉注射的BMSCs能向肺癌肿瘤特异性趋化,并在活体缩短成瘤时间[A549细胞+BMSCs组和A549细胞组分别为(5.0±1.5)d和(10.0±3.6)d, P<0.05;H446细胞+BMSCs组和H446细胞组分别为(5.2±1.5)d和(12.0±2.0)d, P<0.05)],提高成瘤率(A549细胞+BMSCs组和A549细胞组分别为100.0%和66.7%, P<0.05;H446细胞+BMSCs组和H446细胞组分别为83.0%和50.0%, P<0.05),增大肿瘤体积[A549细胞+BMSCs组和A549细胞组分别为(193.0±42.3)mm(3)和(97.8±42.9)mm(3,) P<0.05;H446细胞+BMSCs组和H446细胞组分别为(78.6±34.8)mm(3)和(25.3±12.7)mm(3,) P<0.05)],促进转移(A549细胞+BMSCs组和A549细胞组肝转移率分别为100.0%和16.7%, P<0.05;H446细胞+BMSCs组和H446细胞组分别为100.0%和0.0%, P<0.05),增加肿瘤MVD(A549细胞+BMSCs组和A549细胞组分别为53.2±11.4和25.3±11.5, P<0.05;H446细胞+BMSCs组和H446细胞组分别为56.8±12.5和24.8±10.0, P<0.05)。BMSCs可分化形成肺鳞癌中的肌成纤维细胞。在BMSCs的作用下,肺癌细胞的迁移速度更快,跨膜侵袭的能力更强(A549细胞对照组、A549细胞实验组下室的吸光度分别为1.1±0.1和1.9±0.2,H446细胞对照组、H446细胞实验组下室的吸光度分别为0.9±0.2和1.9±0.3,均P<0.05),细胞形态更长更细,细胞间连接明显减少,E-钙黏蛋白(E-Cadherin)表达明显降低(A549细胞对照组、A549细胞实验组E-Cadherin表达水平分别为0.55和0.36,H446细胞对照组、H446细胞实验组E-Cadherin表达水平分别为0.46和0.28,均P<0.05)。BMSCs条件介质中,白细胞介素6(IL-6)的分泌明显升高,前列腺素E2(PGE2)在BMSCs与肺癌细胞相互作用后表达升高。 结论: BMSCs可能通过促微血管形成促进肿瘤生长,通过旁分泌增加肺癌细胞的迁移、侵袭能力,下调E-Cadherin表达,进而促进其转移,而IL-6和PGE2可能是发挥作用的主要细胞因子。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Luo D, Hu SY, Liu GX, et al. [Multi-channel promotion of lung cancer progress by bone marrow derived mesenchymal stem cells in tumor microenvironment]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29502366. doi:10.3760/cma.j.issn.0253-3766.2018.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。